Más de un año, concretamente 378 días, es el tiempo que han transcurrido aisladas cuatro personas que han protagonizado un singular experimento de estancia simulada en Marte. El experimento se ha desarrollado en unas instalaciones especiales del Centro Espacial Johnson de la NAS …
Más de un año viviendo y trabajando como en Marte Read More »
El litio es vital para muchas tecnologías actuales, incluyendo, por ejemplo los teléfonos inteligentes, los automóviles eléctricos y las redes de suministro de electricidad. La demanda de litio ha crecido tanto que su extracción se ha vuelto problemática. Un …
Nuevo método para extraer litio de donde era inviable hacerlo Read More »
Pfizer is calling upon lessons learned from one of the first drugs ever made available on the internet—Viagra—as it commercializes a new obesity drug in China.
Pfizer, fresh to China’s obesity market, looks to Viagra model to compete Read More »
Patients, providers and medtech firms submitted hundreds of comments to the Food and Drug Administration on how the agency should approach generative AI in medical devices.
How should the FDA regulate generative AI in medtech? Here are 5 takes Read More »
Compass Pathways revealed that an FDA filing for COMP360 will be complete “in the next two weeks,” with an expected drug launch in the first half of next year. The update follows a reported regulatory submission for Usona Institute’s own psilocybin candidate for depression on Monday.
Compass to submit psilocybin depression drug for approval imminently after stock wobbles Read More »
The Sanford, North Carolina, facility will become the company’s first manufacturing facility for injectable contrast media in the U.S.
Bracco invests $230M to build US plant for injectable contrast media Read More »
The Swiss contract development and manufacturing organization will more than double its U.S. footprint by acquiring the Merck KGaA plants.
Lonza agrees to buy 5 Merck KGaA facilities to accelerate US expansion Read More »
In a new issue brief, the AMA assigns physicians, AI developers and healthcare organizations distinct responsibilities regarding clinical AI, arguing that protecting patients requires all stakeholders to be accountable for their part in the AI ecosystem.
AI vendors, health systems join physicians in liability for clinical AI: AMA Read More »
The nonprofit health systems officially combined on Sunday following approval from state regulators. Tacoma, Washington-based MultiCare will invest $700 million over the next decade in Samaritan’s facilities and technology.
Neurocrine Biosciences will conduct a new study for the rare disease drug Vykat to explore dosing and safety in patients with Prader-Willi syndrome who have complex health issues.
Neurocrine defends Prader-Willi drug after another patient death Read More »
